Fingerprint
Dive into the research topics of 'Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs - an open-label study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Amantadine augmentation therapy for obsessive compulsive patients resistant to SSRIs - an open-label study
Rafael Stryjer*, Dana Budnik, Tania Ebert, Tamar Green, Lea Polak, Shira Weizman, Baruch Spivak
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review